| Literature DB >> 17289807 |
Irene E Zohn1, Ivana De Domenico, Andrew Pollock, Diane McVey Ward, Jessica F Goodman, Xiayun Liang, Amaru J Sanchez, Lee Niswander, Jerry Kaplan.
Abstract
Ferroportin disease is caused by mutation of one allele of the iron exporter ferroportin (Fpn/IREG1/Slc40a1/MTP1). All reported human mutations are missense mutations and heterozygous null mutations in mouse Fpn do not recapitulate the human disease. Here we describe the flatiron (ffe) mouse with a missense mutation (H32R) in Fpn that affects its localization and iron export activity. Similar to human patients with classic ferroportin disease, heterozygous ffe/+ mice present with iron loading of Kupffer cells, high serum ferritin, and low transferrin saturation. In macrophages isolated from ffe/+ heterozygous mice and through the use of Fpn plasmids with the ffe mutation, we show that Fpn(ffe) acts as a dominant negative, preventing wild-type Fpn from localizing on the cell surface and transporting iron. These results demonstrate that mutations in Fpn resulting in protein mislocalization act in a dominant-negative fashion to cause disease, and the Fpn(ffe) mouse represents the first mouse model of ferroportin disease.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17289807 PMCID: PMC1885502 DOI: 10.1182/blood-2007-01-066068
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113